Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats

Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats
复制标题

DOI:
10.1016/s0006-8993(97)01500-x
复制
发表时间:
1998-03-23
期刊:
影响因子:
2.9
通讯作者:
Bradford, HF
Bradford, HF
中科院分区:
医学3区
文献类型:
--
作者:
Attwell, PJE;Koumentaki, A;Bradford, HF

文献摘要

被引文献

相似文献

测试了脑内给予II组代谢型谷氨酸受体激动剂2 R,4 R-APDC对杏仁核点燃发展和完全发展的第5期杏仁核点燃癫痫发作的影响。在8天的时间内,与对照动物相比,2 R,4 R-APDC(10 nmol,0.5 μ l)治疗动物的杏仁核点燃的发展显着延迟。在低剂量下,2 R,4 R-APDC(0.1 nmol)导致完全点燃动物的全身癫痫发作阈值增加42.5 +/- 26.6%。然而,随着给药剂量的增加,全身性癫痫发作阈值的变化不太明显,甚至可以观察到阈值的小幅降低(10 nmol时为-19.6 +/- 5.36%)。激动剂2 R,4 R-APDC抑制去极化诱导的皮质突触体释放[H-3] D-天冬氨酸,IC 50值为0.29 μ M。这种作用在1 μ M时最大,此后随剂量增加而降低。这些结果表明,选择性激活组II代谢型谷氨酸受体的激动剂,如2 R,4 R-APDC可能是治疗癫痫发作疾病的治疗潜力。(C)1998年Elsevier Science B.V.
The effects of intracerebral administration of the group II metabotropic glutamate receptor agonist, 2R,4R-APDC, were tested on both the development of amygdaloid kindling and on fully developed stage 5 amygdala kindled seizures. The development of amygdaloid kindling was significantly retarded in 2R,4R-APDC (10 nmol in 0.5 mu l) treated animals compared to control animals over a period of 8 days. At a low dose, 2R,4R-APDC (0.1 nmol) caused a 42.5 +/- 26.6% increase of the generalised seizure threshold in fully kindled animals. As higher doses were administered, however, the changes in generalised seizure threshold were less marked, and even a small decrease in the threshold was seen (-19.6 +/- 5.36% at 10 nmol). The agonist 2R,4R-APDC inhibited depolarization-induced release of [H-3]D-aspartate from cortical synaptosomes with an IC50 value of 0.29 mu M. This effect was maximal at 1 mu M, and decreased with dose thereafter. These findings suggest that the selective activation of the group II metabotropic glutamate receptors by agonists such as 2R,4R-APDC may be of therapeutic potential in the treatment of seizure disorders. (C) 1998 Elsevier Science B.V.